• Je něco špatně v tomto záznamu ?

Referral of intravenous drug users for antiviral treatment: effectiveness of hepatitis C case-finding programmes

G. Gazdag, G. Horváth, O. Szabó, GS. Ungvari

. 2012 ; 20 (3) : 223-225.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13003362

Digitální knihovna NLK
Zdroj

E-zdroje Online Plný text

NLK Free Medical Journals od 2004
ProQuest Central od 2009-03-01 do Před 6 měsíci
Medline Complete (EBSCOhost) od 2006-03-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2009-03-01 do Před 6 měsíci
Public Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources od 1993

Odkazy

PubMed 23285525
DOI 10.21101/cejph.a3747
Knihovny.cz E-zdroje

BACKGROUND: Hepatitis C infection (HCI) case-finding programmes aim to identify infected persons in a well-defined population. This study assessed the effectiveness of three HCI case-finding programmes for intravenous drug usersBy examining the rate of their referral to antiviral treatment. METHODS: The Hepatology Outpatient Clinic of Szent László Hospital examines and treats all intravenous drug users who are found positive in HCI case-finding programmes inBudapest. The medical records of patients who visited the Hepatology Outpatient Clinic of Szent László HospitalBetween 1 January 2006 and 31 December 2008 were screened and records indicating a history of drug abuse were selected. These records were matched against the databases of the hepatitis case-finding programmes and the records that appeared inBoth datasets were analyzed. RESULTS: Of the 234 intravenous drug users identified as hepatitis C virus positive in theBudapest case-finding programmes, only 21 attended the Hepatology Outpatient Clinic of Szent László Hospital and only two started antiviral treatment,But their hepatitis C virus positive status had alreadyBeen known at the time of screening. CONCLUSION: In this study, not a single patient with drug abuse whose hepatitis C virus positive status was identified in one of the HCI case-finding programmes was referred for antiviral treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13003362
003      
CZ-PrNML
005      
20130204090456.0
007      
ta
008      
130124s2012 xr f 000 0|eng||
009      
AR
024    7_
$a 10.21101/cejph.a3747 $2 doi
035    __
$a (PubMed)23285525
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Gazdag, Gábor $u Consultation-Liaison Psychiatric Service, Szent István and Szent László Hospitals, Budapest, Hungary. gazdag@lamb.hu
245    10
$a Referral of intravenous drug users for antiviral treatment: effectiveness of hepatitis C case-finding programmes / $c G. Gazdag, G. Horváth, O. Szabó, GS. Ungvari
520    9_
$a BACKGROUND: Hepatitis C infection (HCI) case-finding programmes aim to identify infected persons in a well-defined population. This study assessed the effectiveness of three HCI case-finding programmes for intravenous drug usersBy examining the rate of their referral to antiviral treatment. METHODS: The Hepatology Outpatient Clinic of Szent László Hospital examines and treats all intravenous drug users who are found positive in HCI case-finding programmes inBudapest. The medical records of patients who visited the Hepatology Outpatient Clinic of Szent László HospitalBetween 1 January 2006 and 31 December 2008 were screened and records indicating a history of drug abuse were selected. These records were matched against the databases of the hepatitis case-finding programmes and the records that appeared inBoth datasets were analyzed. RESULTS: Of the 234 intravenous drug users identified as hepatitis C virus positive in theBudapest case-finding programmes, only 21 attended the Hepatology Outpatient Clinic of Szent László Hospital and only two started antiviral treatment,But their hepatitis C virus positive status had alreadyBeen known at the time of screening. CONCLUSION: In this study, not a single patient with drug abuse whose hepatitis C virus positive status was identified in one of the HCI case-finding programmes was referred for antiviral treatment.
650    _2
$a antivirové látky $x terapeutické užití $7 D000998
650    _2
$a zdravé chování $7 D015438
650    _2
$a zdravotnické služby $x využití $7 D006296
650    _2
$a hepatitida C $x diagnóza $x epidemiologie $x terapie $7 D006526
650    _2
$a lidé $7 D006801
650    _2
$a plošný screening $x statistika a číselné údaje $7 D008403
650    _2
$a pacientův souhlas se zdravotní péčí $x statistika a číselné údaje $7 D010342
650    _2
$a konziliární vyšetření a konzultace $x statistika a číselné údaje $7 D012017
650    _2
$a intravenózní abúzus drog $x epidemiologie $x terapie $7 D015819
651    _2
$a Maďarsko $x epidemiologie $7 D006814
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Horváth, Gergely $u Focal Point for Drugs, National Epidemiological Center, Budapest, Hungary
700    1_
$a Szabó, Olga $u Hepatology Outpatient Clinic, Szent István and Szent László Hospitals, Budapest, Hungary
700    1_
$a Ungvari, Gabor S $u Univesity of Notre Dame Australia, Marian Centre, Perth, Australia
773    0_
$w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 20, č. 3 (2012), s. 223-225
910    __
$a ABA008 $b B 1829 $c 562 $y 3 $z 0
990    __
$a 20130124 $b ABA008
991    __
$a 20130204090628 $b ABA008
999    __
$a ok $b bmc $g 966933 $s 801555
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 20 $c 3 $d 223-225 $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
LZP    __
$b NLK138 $a Pubmed-20130124

Najít záznam

Citační ukazatele

Možnosti archivace